ClinicalTrials.gov
ClinicalTrials.gov Menu

Mental Health Engagement Network (MHEN) (MHEN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01473550
Recruitment Status : Completed
First Posted : November 17, 2011
Last Update Posted : March 7, 2016
Sponsor:
Collaborators:
London Health Sciences Centre
Canadian Mental Health Association
St. Joseph's Health Care London
Information provided by (Responsible Party):
Cheryl Forchuk, Lawson Health Research Institute

Brief Summary:
Patients with mood disorder or psychotic disorder will be given handheld devices with personal health records to educate, monitor and deliver customizable healthcare tools based on their personal needs. The use of technology has great potential to deliver care more effectively and efficiently. No actual information is on the handheld device - it is accessed from a secure site behind hospital firewalls.

Condition or disease Intervention/treatment Phase
Mood Disorder Psychotic Disorder Behavioral: Access to TELUS Health Space and Smart Phone Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 400 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: Mental Health Engagement Network (MHEN): Connecting Clients With Their Health Team
Study Start Date : November 2011
Actual Primary Completion Date : June 2014
Actual Study Completion Date : June 2014

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: Early Intervention
At Phase 1 (first 3 months of project), the 200 participants in Group 1 will be provided with a Personal Health Record (PHR) through TELUS Health Space, as well as they will be introduced to smart phone technology to ready them for deployment of the prompts and reminders. Two months later, they will be provided with a smart phone.
Behavioral: Access to TELUS Health Space and Smart Phone
Participants will be given their own TELUS Health Space and Smart Phone in order to have access to their personal health records. Specific procedures using the smart phone will depend on the individual care plan for each participant. Prompts and assessments will vary depending on participant needs.
Experimental: Later Intervention
A delayed implementation plan will be used (but will have no effect on the standard of care for the remaining 200 participants), so the remaining 200 participants in Group 2 will initially act as a control group, but at Phase 2 (six months later - approximately June 2012) the remaining 200 participants will be introduced to the technology in the same order (PHR -> Smart Phone). Group 2 will have the benefit of any enhancements made during Phase 1 of the project.
Behavioral: Access to TELUS Health Space and Smart Phone
Participants will be given their own TELUS Health Space and Smart Phone in order to have access to their personal health records. Specific procedures using the smart phone will depend on the individual care plan for each participant. Prompts and assessments will vary depending on participant needs.



Primary Outcome Measures :
  1. Lehman Quality of Life - Brief Version [ Time Frame: Every 6 months for total of 18 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Must be diagnosed with mood disorder or psychotic disorder for a minimum one year
  • Able to make informed consent to participate in the study
  • Able to understand and speak English to the degree necessary to participate in interviews/focus groups

Exclusion Criteria:

  • Younger than 18 or older than 80

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01473550


Locations
Canada, Ontario
Canadian Mental Health Association (London-Middlesex Branch)
London, Ontario, Canada, N5Y4J8
Regional Mental Health Care
London, Ontario, Canada, N6A4H1
London Health Sciences Centre
London, Ontario, Canada, N6A5W9
Western Ontario Therapeutic Community Hostel
London, Ontario, Canada, N6B1Y6
Sponsors and Collaborators
Lawson Health Research Institute
London Health Sciences Centre
Canadian Mental Health Association
St. Joseph's Health Care London
Investigators
Principal Investigator: Cheryl Forchuk, PhD Lawson Health Research Institute; University of Western Ontario

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Cheryl Forchuk, Assistant Director, Lawson Health Research Institute
ClinicalTrials.gov Identifier: NCT01473550     History of Changes
Other Study ID Numbers: 18451
First Posted: November 17, 2011    Key Record Dates
Last Update Posted: March 7, 2016
Last Verified: March 2016

Keywords provided by Cheryl Forchuk, Lawson Health Research Institute:
Mental Health
Smart Technology
Mood disorder
Psychotic disorder

Additional relevant MeSH terms:
Disease
Mental Disorders
Psychotic Disorders
Mood Disorders
Pathologic Processes
Schizophrenia Spectrum and Other Psychotic Disorders